NASDAQ : ACAD
ACADIA Pharmaceuticals Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 20.59 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.55B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
ACADIA Pharmaceuticals Inc. (ACAD) reported revenue of 1.14B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 1.14B | 1.07B | 957.80M | 726.44M | 517.24M | 484.14M |
| Cost of Revenue | 431.99M | 417.80M | 385.09M | 393.26M | 371.74M | 258.56M |
| Gross Profit | 706.66M | 653.71M | 572.71M | 333.18M | 145.49M | 225.59M |
| Selling, General & Admin | 620.29M | 548.89M | 488.43M | 406.56M | 369.09M | 396.03M |
| Operating Expenses | 620.29M | 548.89M | 488.43M | 406.56M | 369.09M | 396.03M |
| Operating Income | 86.37M | 104.81M | 84.28M | -73.38M | -223.60M | -170.44M |
| Interest & Investment Income | 32.62M | 31.72M | 25.46M | 17.23M | 6.61M | 591.00K |
| Other Non Operating Income (Expenses) | 2.38M | 2.37M | 1.82M | |||
| EBT Excluding Unusual Items | 121.37M | 138.90M | 111.56M | -56.15M | -216.99M | -169.85M |
| Gain (Loss) on Sale of Investments | 5.11M | 3.54M | 2.33M | |||
| Gain (Loss) on Sale of Assets | 146.51M | |||||
| Pretax Income | 121.37M | 138.90M | 258.07M | -51.04M | -213.44M | -167.52M |
| Income Tax Expense | -259.12M | -252.10M | 31.62M | 10.25M | 2.53M | 351.00K |
| Net Income | 380.48M | 391.00M | 226.45M | -61.29M | -215.97M | -167.87M |
| Net Income to Common | 380.48M | 391.00M | 226.45M | -61.29M | -215.97M | -167.87M |
| Shares Outstanding (Basic) | 170.23M | 168.36M | 165.72M | 163.82M | 161.68M | 160.49M |
| Shares Outstanding (Diluted) | 172.25M | 169.92M | 166.36M | 163.82M | 161.68M | 160.49M |
| EPS (Basic) | 2.24 | 2.32 | 1.37 | -0.37 | -1.34 | -1.05 |
| EPS (Diluted) | 2.21 | 2.30 | 1.36 | -0.37 | -1.34 | -1.05 |
| Free Cash Flow | 145.62M | 105.15M | 157.20M | 16.65M | -114.03M | -126.78M |
| Free Cash Flow Per Share | 0.84 | 0.62 | 0.94 | 0.10 | -0.70 | -0.79 |
| Gross Margin | 62.06% | 61.01% | 59.79% | 45.87% | 28.13% | 46.59% |
| Operating Margin | 7.58% | 9.78% | 8.80% | -10.10% | -43.23% | -35.20% |
| Profit Margin | 33.42% | 36.49% | 23.64% | -8.44% | -41.76% | -34.67% |
| Free Cash Flow Margin | 12.79% | 9.81% | 16.41% | 2.29% | -22.05% | -26.19% |
| EBITDA | 98.39M | 116.57M | 100.16M | -67.83M | -221.57M | -167.09M |
| EBITDA Margin | 8.64% | 10.88% | 10.46% | -9.34% | -42.84% | -34.51% |
| D&A For EBITDA | 12.02M | 11.76M | 15.88M | 5.55M | 2.03M | 3.34M |
| EBIT | 86.37M | 104.81M | 84.28M | -73.38M | -223.60M | -170.44M |
| EBIT Margin | 7.58% | 9.78% | 8.80% | -10.10% | -43.23% | -35.20% |
| Effective Tax Rate | 12.25% | |||||
| Revenue as Reported | 1.14B | 1.07B | 957.80M | 726.44M | 517.24M | 484.14M |
| Advertising Expenses | 31.90M | 21.10M | 9.40M | 5.50M | 41.80M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 384.99M | 177.69M | 319.59M | 188.66M | 114.85M | 147.44M |
| Short-Term Investments | 571.49M | 641.99M | 436.40M | 250.21M | 301.98M | 373.27M |
| Cash & Short-Term Investments | 956.47M | 819.69M | 755.99M | 438.87M | 416.82M | 520.71M |
| Accounts Receivable | 150.64M | 121.46M | 98.74M | 98.27M | 62.20M | 64.37M |
| Other Receivables | 15.69M | 26.77M | 5.96M | 4.08M | 885.00K | 978.00K |
| Receivables | 166.33M | 148.23M | 104.69M | 102.35M | 63.08M | 65.34M |
| Inventory | 32.37M | 34.67M | 21.95M | 35.82M | 6.64M | 7.88M |
| Prepaid Expenses | 69.37M | 59.53M | 55.68M | 39.09M | 21.40M | 23.89M |
| Total Current Assets | 1.22B | 1.06B | 938.32M | 616.12M | 507.94M | 617.82M |
| Property, Plant & Equipment | 86.53M | 54.87M | 50.79M | 56.47M | 61.59M | 66.31M |
| Long-Term Investments | 3.60M | |||||
| Other Intangible Assets | 103.45M | 108.89M | 119.78M | 65.49M | ||
| Long-Term Deferred Tax Assets | 240.68M | 249.88M | ||||
| Other Long-Term Assets | 87.70M | 88.44M | 78.87M | 10.87M | 18.28M | 12.38M |
| Total Assets | 1.74B | 1.56B | 1.19B | 748.96M | 587.81M | 700.12M |
| Accounts Payable | 44.57M | 10.90M | 16.19M | 17.54M | 12.75M | 6.88M |
| Accrued Expenses | 302.56M | 254.27M | 254.44M | 196.16M | 103.58M | 80.89M |
| Current Portion of Leases | 14.31M | 11.63M | 9.96M | 9.40M | 9.30M | 8.30M |
| Current Income Taxes Payable | 304.00K | 12.02M | 1.56M | |||
| Other Current Liabilities | 102.26M | 29.58M | ||||
| Total Current Liabilities | 361.44M | 277.11M | 394.87M | 254.25M | 125.63M | 96.07M |
| Long-Term Leases | 59.55M | 40.55M | 42.04M | 47.80M | 52.70M | 56.13M |
| Other Long-Term Liabilities | 15.31M | 19.14M | 18.06M | 15.15M | 9.07M | 7.03M |
| Total Liabilities | 436.29M | 336.81M | 454.96M | 317.20M | 187.40M | 159.23M |
| Common Stock | 16.00K | 16.00K | 16.00K | 16.00K | 16.00K | 16.00K |
| Additional Paid-In Capital | 3.09B | 3.04B | 2.94B | 2.86B | 2.77B | 2.69B |
| Retained Earnings | -1.78B | -1.81B | -2.20B | -2.43B | -2.37B | -2.15B |
| Comprehensive Income & Other | -958.00K | 1.45M | 292.00K | 24.00K | -975.00K | -192.00K |
| Shareholders' Equity | 1.31B | 1.23B | 732.79M | 431.75M | 400.41M | 540.89M |
| Total Liabilities & Equity | 1.74B | 1.56B | 1.19B | 748.96M | 587.81M | 700.12M |
| Total Debt | 73.85M | 52.19M | 51.99M | 57.20M | 62.00M | 64.43M |
| Net Cash (Debt) | 882.62M | 767.50M | 704.00M | 381.66M | 354.82M | 456.28M |
| Net Cash Per Share | 5.12 | 4.52 | 4.23 | 2.33 | 2.19 | 2.84 |
| Filing Date Shares Outstanding | 172.31M | 170.49M | 166.79M | 164.77M | 162.23M | 161.20M |
| Total Common Shares Outstanding | 172.13M | 170.31M | 166.71M | 164.65M | 162.06M | 161.01M |
| Working Capital | 863.11M | 785.00M | 543.45M | 361.87M | 382.31M | 521.75M |
| Book Value Per Share | 7.59 | 7.21 | 4.40 | 2.62 | 2.47 | 3.36 |
| Tangible Book Value | 1.20B | 1.12B | 613.01M | 366.26M | 400.41M | 540.89M |
| Tangible Book Value Per Share | 6.99 | 6.57 | 3.68 | 2.22 | 2.47 | 3.36 |
| Machinery | 9.09M | 10.16M | 10.42M | 10.42M | 10.54M | |
| Construction In Progress | 3.26M | 523.00K | ||||
| Leasehold Improvements | 4.64M | 3.75M | 3.75M | 3.70M | 3.70M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 380.48M | 391.00M | 226.45M | -61.29M | -215.97M | -167.87M |
| Depreciation & Amortization | 12.02M | 11.76M | 15.88M | 5.55M | 2.03M | 3.34M |
| Loss (Gain) From Sale of Assets | -146.51M | |||||
| Loss (Gain) From Sale of Investments | -2.27M | -5.42M | -9.30M | -12.12M | -6.28M | 75.00K |
| Stock-Based Compensation | 58.05M | 52.13M | 67.05M | 66.42M | 68.20M | 63.62M |
| Other Operating Activities | -240.20M | -249.88M | ||||
| Change in Accounts Receivable | -43.14M | -22.72M | -472.00K | -36.07M | 2.17M | -16.12M |
| Change in Inventory | 331.00K | -18.20M | -49.55M | -28.81M | 2.42M | -4.21M |
| Change in Accounts Payable | 24.47M | -5.29M | -1.35M | 4.80M | 5.87M | -1.62M |
| Change in Other Net Operating Assets | -29.43M | -43.55M | 55.53M | 78.22M | 27.54M | -2.88M |
| Operating Cash Flow | 160.32M | 109.84M | 157.72M | 16.70M | -114.03M | -125.66M |
| Capital Expenditures | -14.69M | -4.69M | -523.00K | -50.00K | -1.12M | |
| Sale of Property, Plant & Equipment | 146.51M | |||||
| Sale (Purchase) of Intangibles | -98.84M | -40.00M | ||||
| Investment in Securities | -62.77M | -199.04M | -176.53M | 72.05M | 73.24M | -69.98M |
| Investing Cash Flow | -77.47M | -302.56M | -30.54M | 32.00M | 73.24M | -71.10M |
| Issuance of Common Stock | 46.81M | 49.88M | 6.84M | 25.13M | 8.20M | 18.16M |
| Financing Cash Flow | 46.81M | 49.88M | 6.84M | 25.13M | 8.20M | 18.16M |
| Foreign Exchange Rate Adjustments | 59.00K | 26.00K | -94.00K | -18.00K | 6.00K | 7.00K |
| Net Cash Flow | 129.72M | -142.82M | 133.93M | 73.81M | -32.59M | -178.59M |
| Free Cash Flow | 145.62M | 105.15M | 157.20M | 16.65M | -114.03M | -126.78M |
| Free Cash Flow Margin | 12.79% | 9.81% | 16.41% | 2.29% | -22.05% | -26.19% |
| Free Cash Flow Per Share | 0.84 | 0.62 | 0.94 | 0.10 | -0.70 | -0.79 |
| Levered Free Cash Flow | 68.65M | -153.66M | 270.08M | 28.44M | -34.96M | -65.26M |
| Unlevered Free Cash Flow | 68.65M | -153.66M | 270.08M | 28.44M | -34.96M | -65.26M |
| Cash Income Tax Paid | 25.17M | 25.17M | 19.52M | 5.85M | 2.19M | 1.04M |
| Change in Working Capital | -47.77M | -89.76M | 4.16M | 18.13M | 37.99M | -24.82M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 3.55B | 4.52B | 3.05B | 5.14B | 2.58B | 3.75B |
| Enterprise Value | 2.67B | 3.73B | 2.54B | 4.85B | 2.20B | 3.28B |
| Last Close Price | 20.59 | 26.71 | 18.35 | 31.31 | 15.92 | 23.34 |
| PE Ratio | 9.33 | 11.56 | 13.48 | |||
| Forward PE | 26.16 | 40.38 | 35.90 | 27.40 | ||
| PS Ratio | 3.12 | 4.22 | 3.19 | 7.08 | 4.98 | 7.75 |
| PB Ratio | 2.71 | 3.68 | 4.17 | 11.91 | 6.44 | 6.94 |
| P/TBV Ratio | 2.95 | 4.04 | 4.98 | 14.04 | 6.44 | 6.94 |
| P/FCF Ratio | 24.36 | 42.98 | 19.42 | 308.70 | ||
| P/OCF Ratio | 22.13 | 41.14 | 19.36 | 307.78 | ||
| PEG Ratio | 7.43 | |||||
| EV/Sales Ratio | 2.34 | 3.48 | 2.65 | 6.68 | 4.26 | 6.77 |
| EV/EBITDA Ratio | 27.09 | 31.97 | 25.33 | |||
| EV/EBIT Ratio | 30.86 | 35.56 | 30.11 | |||
| EV/FCF Ratio | 18.30 | 35.44 | 16.14 | 291.36 | ||
| Debt / Equity Ratio | 0.06 | 0.04 | 0.07 | 0.13 | 0.15 | 0.12 |
| Debt / EBITDA Ratio | 0.66 | 0.40 | 0.47 | |||
| Debt / FCF Ratio | 0.51 | 0.50 | 0.33 | 3.44 | ||
| Net Debt / Equity Ratio | -0.68 | -0.62 | -0.96 | -0.88 | -0.89 | -0.84 |
| Net Debt / EBITDA Ratio | -8.97 | -6.58 | -7.03 | 5.63 | 1.60 | 2.73 |
| Net Debt / FCF Ratio | -6.06 | -7.30 | -4.48 | -22.92 | 3.11 | 3.60 |
| Asset Turnover | 0.77 | 0.78 | 0.99 | 1.09 | 0.80 | 0.65 |
| Inventory Turnover | 14.77 | 14.76 | 13.33 | 18.53 | 51.22 | 29.44 |
| Quick Ratio | 3.11 | 3.49 | 2.18 | 2.13 | 3.82 | 6.10 |
| Current Ratio | 3.39 | 3.83 | 2.38 | 2.42 | 4.04 | 6.43 |
| Return on Equity (ROE) | 35.74% | 39.89% | 38.89% | -14.73% | -45.89% | -28.75% |
| Return on Assets (ROA) | 3.64% | 4.76% | 5.44% | -6.86% | -21.70% | -14.37% |
| Return on Invested Capital (ROIC) | 19.82% | 22.79% | -153.38% | -343.44% | -263.80% | |
| Return on Capital Employed (ROCE) | 6.30% | 8.10% | 10.60% | -14.80% | -48.40% | -28.20% |
| Earnings Yield | 10.71% | 8.65% | 7.42% | -1.19% | -8.38% | -4.47% |
| FCF Yield | 4.10% | 2.33% | 5.15% | 0.32% | -4.42% | -3.38% |
| Buyback Yield / Dilution | -2.98% | -2.14% | -1.55% | -1.32% | -0.74% | -2.01% |